Optiscan secures further orders from Carl Zeiss

OptiScan Imaging Limited (ASX: OIL) is pleased to advise that it has received orders from Carl Zeiss Meditec AG pursuant to its Co-operation Agreement for approximately A$350k.

CEO and Executive Chairman Darren Lurie said:
“The orders from CZM represent the continuation of CZM’s commercial rollout of the CONVIVO® developed as part of the co-operation agreement between CZM and OptiScan.

We are also very pleased that OptiScan continues to diversify its revenue streams and cash flows. Receipts in the December 2020 quarter included $570k from the final payments for the 2 (two) FIVE2 (ViewnVivo) systems sold to China based customers, the BioMedTech Horizons Program grant to support the University of Melbourne’s Melbourne Dental School trial and payments from CZM. ”

 

Read the full announcement here: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02330268-3A559418?access_token=83ff96335c2d45a094df02a206a39ff4